But throughout the year, many insurers and employers said they would start restricting or eliminating GLP-1 coverage of drugs for weight loss, while retaining coverage if patients have Type 2 diabetes
They also lower levels of glucagon, a hormone that raises blood sugar
Air bubbles in the syringe barrel displace liquid volume
Plus, 39% state theyre intentionally increasing their probiotics/prebiotics intake
Semaglutide 2.4 mg once weekly is the latest approved GLP-1 RA for obesity management (2021) and results in 1517% mean WL through appetite reduction [11, 12]
Eric Goldstein, a gastroenterologist in New York City, told Insider that while digestive issues are known side effects of this class of drugs, called GLP-1 receptor agonists, how widespread and severe they are is likely overblown on social media